ROS, E. O. The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited. React Oxyg Species (Apex) 2021, 11, n7–n8.